Hansa Biopharma AB (publ) (FRA:24H)
Germany · Delayed Price · Currency is EUR 3.270
+0.348 (11.91%)
At close: Jan 23, 2026
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of €356.82 million as of January 30, 2026. Its market cap has increased by 85.80% in one year.
Market Cap
356.82M
Enterprise Value
420.60M
Revenue
16.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.27
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 3.30M to 356.82M, an increase of 10,725.63%. That is a compound annual growth rate of 30.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 356.82M | 10.33% |
| Dec 30, 2025 | 323.41M | 39.42% |
| Dec 30, 2024 | 231.97M | 88.20% |
| Dec 29, 2023 | 123.25M | -46.81% |
| Dec 30, 2022 | 231.71M | -39.91% |
| Dec 30, 2021 | 385.60M | -63.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wild Bunch AG | 526.74M |
| HOMAG Group AG | 414.16M |
| Eisen- und Hüttenwerke AG | 362.56M |
| Novabase S.G.P.S. | 352.86M |
| SIMONA Aktiengesellschaft | 300.00M |
| EUWAX Aktiengesellschaft | 267.80M |
| centrotherm international AG | 241.25M |
| STINAG Stuttgart Invest AG | 232.23M |